Commercialization And Logistics
-
Scaling Viral Vectors
11/13/2023
Industry experts cover the high operational costs associated with viral vectors, along with the challenge presented by their shot shelf life and scalability.
-
A Successful Journey To Cell Therapy Manufacturing
5/29/2025
Learn about the three main areas to consider when you're preparing to commercialize a cell therapy, including starting/raw material, the controlled manufacturing process, as well as testing safety and quality.
-
Bioprocessing Solutions For Cell Culture
6/16/2025
Whatever the scope of your project, you can choose from our unmatched portfolio of high-impact produCTS and services to deliver consistent, scalable solutions.
-
Singapore Single-Use Site Capacity Expansion
6/1/2022
Thermo Fisher Scientific is expanding our single-use manufacturing network globally, an expansion site closer to Asia Pacific region
-
Driving Down COGS Audience Q&A
8/18/2023
Expert panelists provide detailed answers to questions submitted in real time by our registrants providing insightful responses regarding analytical challenges to automation, test automation, and more.
-
Enhancing AAV Purification In Gene Therapy Manufacturing
6/2/2025
Review chromatography solutions for purifying multiple AAV serotypes, with specialists’ insights on bioprocessing and downstream optimization.
-
Leveraging Rapid Sterility Testing To Advance Cell Therapy Production
6/23/2025
Explore the crucial role of rapid sterility testing in cell therapy manufacturing. This presentation delves into the benefits of swift, accurate detection for product quality and patient safety.
-
An Active Release Mechanism For Magnetic Separation And Cell Isolation
11/13/2023
Discover an innovative active release solution that will serve autologous and allogeneic processes to the benefit of cell therapy patients.
-
Safety And Efficiency Of Source Material Collection
8/18/2023
Expert CTO's detail how automation improves safety and efficiency when collecting source material.
-
Manufacturing Considerations For Viral & Non-Viral Platform Selection
6/24/2025
In this webinar, a panel of experts spanning the lentiviral vector, exosome and oncolytic virus fields will discuss the impact of manufacturing considerations on their respective platform selection and ongoing product/process development strategies.